146 related articles for article (PubMed ID: 23333429)
1. Specific inhibition of caspase-3 by a competitive DARPin: molecular mimicry between native and designed inhibitors.
Schroeder T; Barandun J; Flütsch A; Briand C; Mittl PR; Grütter MG
Structure; 2013 Feb; 21(2):277-89. PubMed ID: 23333429
[TBL] [Abstract][Full Text] [Related]
2. Combined inhibition of caspase 3 and caspase 7 by two highly selective DARPins slows down cellular demise.
Flütsch A; Ackermann R; Schroeder T; Lukarska M; Hausammann GJ; Weinert C; Briand C; Grütter MG
Biochem J; 2014 Jul; 461(2):279-90. PubMed ID: 24779913
[TBL] [Abstract][Full Text] [Related]
3. XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs.
Scott FL; Denault JB; Riedl SJ; Shin H; Renatus M; Salvesen GS
EMBO J; 2005 Feb; 24(3):645-55. PubMed ID: 15650747
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanism.
Schweizer A; Roschitzki-Voser H; Amstutz P; Briand C; Gulotti-Georgieva M; Prenosil E; Binz HK; Capitani G; Baici A; Plückthun A; Grütter MG
Structure; 2007 May; 15(5):625-36. PubMed ID: 17502107
[TBL] [Abstract][Full Text] [Related]
5. Molecular insight into the role of the leucine residue on the L2 loop in the catalytic activity of caspases 3 and 7.
Kang HJ; Lee YM; Jeong MS; Kim M; Bae KH; Kim SJ; Chung SJ
Biosci Rep; 2012 Jun; 32(3):305-13. PubMed ID: 22304005
[TBL] [Abstract][Full Text] [Related]
6. A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases.
Abhari BA; Davoodi J
J Mol Biol; 2008 Sep; 381(3):645-54. PubMed ID: 18619610
[TBL] [Abstract][Full Text] [Related]
7. Specific targeting of human caspases using designed ankyrin repeat proteins.
Flütsch A; Schroeder T; Barandun J; Ackermann R; Bühlmann M; Grütter MG
Biol Chem; 2014 Oct; 395(10):1243-52. PubMed ID: 25153593
[TBL] [Abstract][Full Text] [Related]
8. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis.
Srinivasula SM; Hegde R; Saleh A; Datta P; Shiozaki E; Chai J; Lee RA; Robbins PD; Fernandes-Alnemri T; Shi Y; Alnemri ES
Nature; 2001 Mar; 410(6824):112-6. PubMed ID: 11242052
[TBL] [Abstract][Full Text] [Related]
9. Structural asymmetry of procaspase-7 bound to a specific inhibitor.
Kang HJ; Lee YM; Bae KH; Kim SJ; Chung SJ
Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1514-21. PubMed ID: 23897474
[TBL] [Abstract][Full Text] [Related]
10. Conformational similarity in the activation of caspase-3 and -7 revealed by the unliganded and inhibited structures of caspase-7.
Agniswamy J; Fang B; Weber IT
Apoptosis; 2009 Oct; 14(10):1135-44. PubMed ID: 19655253
[TBL] [Abstract][Full Text] [Related]
11. Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids.
Vickers CJ; González-Páez GE; Wolan DW
ACS Chem Biol; 2013 Jul; 8(7):1558-66. PubMed ID: 23614665
[TBL] [Abstract][Full Text] [Related]
12. Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP.
Silke J; Ekert PG; Day CL; Hawkins CJ; Baca M; Chew J; Pakusch M; Verhagen AM; Vaux DL
EMBO J; 2001 Jun; 20(12):3114-23. PubMed ID: 11406588
[TBL] [Abstract][Full Text] [Related]
13. Ac-tLeu-Asp-H is the minimal and highly effective human caspase-3 inhibitor: biological and in silico studies.
Ferrucci A; Leboffe L; Agamennone M; Di Pizio A; Fiocchetti M; Marino M; Ascenzi P; Luisi G
Amino Acids; 2015 Jan; 47(1):153-62. PubMed ID: 25331424
[TBL] [Abstract][Full Text] [Related]
14. Chaperone-assisted crystallography with DARPins.
Sennhauser G; Grütter MG
Structure; 2008 Oct; 16(10):1443-53. PubMed ID: 18940601
[TBL] [Abstract][Full Text] [Related]
15. Designed ankyrin repeat protein binders for the crystallization of AcrB: plasticity of the dominant interface.
Monroe N; Sennhauser G; Seeger MA; Briand C; Grütter MG
J Struct Biol; 2011 May; 174(2):269-81. PubMed ID: 21296164
[TBL] [Abstract][Full Text] [Related]
16. Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.
Fang B; Fu G; Agniswamy J; Harrison RW; Weber IT
Apoptosis; 2009 May; 14(5):741-52. PubMed ID: 19283487
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic and structural understanding of uncompetitive inhibitors of caspase-6.
Heise CE; Murray J; Augustyn KE; Bravo B; Chugha P; Cohen F; Giannetti AM; Gibbons P; Hannoush RN; Hearn BR; Jaishankar P; Ly CQ; Shah K; Stanger K; Steffek M; Tang Y; Zhao X; Lewcock JW; Renslo AR; Flygare J; Arkin MR
PLoS One; 2012; 7(12):e50864. PubMed ID: 23227217
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of N-acyl-substituted 1,2-benzisothiazol-3-one derivatives as caspase-3 inhibitors.
Li Z; Pan Y; Zhong W; Zhu Y; Zhao Y; Li L; Liu W; Zhou H; Yang C
Bioorg Med Chem; 2014 Dec; 22(24):6735-45. PubMed ID: 25468037
[TBL] [Abstract][Full Text] [Related]
19. A designed ankyrin repeat protein evolved to picomolar affinity to Her2.
Zahnd C; Wyler E; Schwenk JM; Steiner D; Lawrence MC; McKern NM; Pecorari F; Ward CW; Joos TO; Plückthun A
J Mol Biol; 2007 Jun; 369(4):1015-28. PubMed ID: 17466328
[TBL] [Abstract][Full Text] [Related]
20. DARPin-Based Crystallization Chaperones Exploit Molecular Geometry as a Screening Dimension in Protein Crystallography.
Batyuk A; Wu Y; Honegger A; Heberling MM; Plückthun A
J Mol Biol; 2016 Apr; 428(8):1574-88. PubMed ID: 26975886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]